International Response Intensifies After Cruise Ship-Linked Andes Virus Outbreak

• The outbreak involves the Andes virus, the only hantavirus known to spread person-to-person.  

• The public health risk for the general population is low. Unlike SARS-CoV-2, the Andes virus is not considered highly transmissible and is not associated with efficient asymptomatic spread.  

• The cruise ship environment likely amplified transmission risk through prolonged close contact, shared cabins, communal dining areas, and delayed identification of the outbreak.   

On May 2, a cluster of passengers with severe respiratory illness aboard a cruise ship carrying passengers and crew from 23 countries was reported to the WHO. At that time, 147 individuals remained onboard, while 34 individuals had already disembarked before the outbreak was recognized. As of May 12, 11 hantavirus cases linked to the outbreak had been identified. Three deaths have been reported, resulting in an estimated case fatality ratio (CFR) of approximately 33 percent. Several patients remain hospitalized in South Africa, Switzerland, France, and other countries. All eleven cases are among passengers or crew on the ship.

Recent additional cases include a confirmed case in France involving a passenger who developed symptoms during a repatriation flight to Paris, a provisional positive asymptomatic case in Spain, and  American passengers, including one who displayed mild symptoms with inconclusive or mildly positive PCR results, are being managed under quarantine in the US.  

The vessel arrived at the port of Granadilla, Tenerife, on May 10, where Spanish authorities and international health agencies coordinated a controlled disembarkation and repatriation operation. Passengers were transferred under managed transport arrangements designed to minimize exposure risks to local populations. Exposed passengers and crew have since entered quarantine or active monitoring arrangements across multiple countries. The vessel is expected to return to the Netherlands with a reduced crew complement, where the vessel will undergo disinfection procedures. Crew members completing the voyage are reportedly expected to undergo a quarantine period before onward travel.  

Epidemiological investigations increasingly support that the outbreak originated from environmental exposure to infected rodents in Argentina or Chile prior to embarkation. Case 1, an adult male who traveled for more than three months in endemic areas of Argentina, Chile, and Uruguay before boarding on April 1, is considered the most likely index case. The case developed symptoms on April 6 and died onboard on April 11. Exposure is thought to have occurred during rural activities such as birdwatching in areas where rodent reservoirs are known to circulate, and several subsequent cases had close contact with the case during their symptomatic period.  

The cruise ship environment likely created favorable conditions for limited transmission due to shared cabins, communal dining facilities, prolonged social interaction, and delayed recognition of the outbreak. No confirmed secondary cases have been identified among individuals who were not aboard the vessel as of May 11.  

The Andes virus is the only hantavirus known to spread between humans. However, health authorities continue to emphasize that Andes hantavirus differs fundamentally from SARS-CoV-2 and other highly transmissible respiratory viruses. Unlike COVID-19, Andes virus transmission generally requires close and prolonged exposure and is not associated with efficient asymptomatic spread.  

The outbreak response has involved extensive multinational coordination due to the vessel’s international passenger profile. The WHO, ECDC, CDC, and multiple national public health agencies continue to coordinate contact tracing, passenger monitoring, laboratory analysis, and repatriation efforts. Several countries have implemented precautionary quarantine protocols for returning passengers. In the US, returning passengers were transported to specialized facilities in Nebraska and Atlanta, including biocontainment-capable units for higher-risk individuals. Spain placed returning nationals under mandatory quarantine at a military hospital in Madrid, while the UK and several European countries introduced monitoring and self-isolation measures.  

Beyond the immediate epidemiological risks, the outbreak has exposed several broader challenges affecting global outbreak preparedness and response in the post-COVID environment. International coordination has proven operationally complex due to the multinational nature of the exposure event and the movement of passengers before the outbreak was recognized. Coordinating quarantine procedures, laboratory testing, risk communication, and repatriation across multiple jurisdictions has required substantial international cooperation.  

Misinformation and public anxiety have also complicated response efforts. Comparisons to COVID-19 have circulated widely online despite major epidemiological differences between the two diseases.  

Hantaviruses are a group of viruses carried by rodents that can cause severe disease in humans. Hantavirus cardiopulmonary syndrome (HCPS), also known as hantavirus pulmonary syndrome (HPS), is a zoonotic, viral respiratory disease. It is primarily transmitted through contact with the urine, feces, or saliva of infected rodents or by touching contaminated surfaces.  Symptoms typically include headache, dizziness, chills, fever, myalgia, and gastrointestinal symptoms, such as nausea, vomiting, diarrhea, and abdominal pain, followed by the sudden onset of respiratory distress and hypotension.  

The severity of illness associated with the Andes virus remains a significant concern. The current outbreak’s CFR is consistent with previous outbreaks and may reflect the older passenger population aboard the vessel, whose average age was around 65 years.  

There is currently no licensed vaccine or specific antiviral treatment for hantavirus infection. Management relies on early detection, supportive care, respiratory support, and access to advanced critical care services.  

Additional cases associated with the outbreak remain possible during the coming weeks as exposed passengers and crew complete the known incubation period, which may extend up to eight weeks following exposure. Most additional detections are likely to occur among identified close contacts already under active monitoring or quarantine arrangements.  

Current evidence continues to indicate that sustained international human-to-human transmission is unlikely. The absence of confirmed secondary transmission outside the vessel, combined with the virus’s limited transmissibility and the extensive containment measures already implemented, strongly supports the current assessment that the broader public health risk remains low.  

Near-term operational challenges are expected to focus on ongoing clinical management of severe cases, coordination of multinational monitoring efforts, completion of contact tracing activities, management of misinformation and public anxiety, and continued laboratory investigations into transmission pathways aboard the vessel.  

Overall, the outbreak represents a serious but currently contained international infectious disease event. The public health risk is moderate for directly exposed passengers, crew members, and close contacts, but low for the wider global population. This represents the most complete data available as of May 12.  

Learn more about leveraging our industry-leading regional and medical experts for intelligence that helps your organization stay ahead of health risks to your people and operations.